Literature DB >> 18588473

Silencing of the expression of pluripotent driven-reporter genes stably transfected into human pluripotent cells.

Rebecca Stewart1, Chunbo Yang, George Anyfantis, Stefan Przyborski, Nicholas Hole, Tom Strachan, Miodrag Stojkovic, W Nicol Keith, Lyle Armstrong, Majlinda Lako.   

Abstract

AIMS &
METHODS: Marking of human embryonic stem (ES) and embryonal carcinoma (EC) cells with pluripotent promoter-driven reporter gene cassettes provides an important tool for studies related to maintenance of pluripotency, cell differentiation and cell selection. OCT4, TERF1 and telomerase reverse transcriptase component (TERT) are considered as pluripotent marker genes since they are expressed in both human ES and EC cells and significantly downregulated during the differentiation process. Our aim was to use core promoter regions from such pluripotent genes to drive expression of reporter genes that would be suitable for human ES cell selection amongst differentiated cells.
RESULTS: Human ES and EC cells were stably transfected with a number of TERT, OCT4 and TERF1 promoter-driven EGFP or NTR gene cassettes. Gradual loss of reporter gene expression was observed from 24 h post-transfection during transient transfection studies, while almost complete loss of reporter expression was observed upon stable transfections. The loss of reporter gene expression was partly reversed by addition of a histone deacetylase inhibitor and a demethylating agent, suggesting that in vitro methylation of these exogenous constructs and the epigenetic architecture around the site of integration are likely to play a major role in their transcriptional activity. Inclusion of gene-regulatory elements in addition to the core promoters has been shown to minimize such effects and should be considered as an important strategy in such studies.
CONCLUSIONS: Together our data suggest that human ES and EC cells are able to silence pluripotent promoter-driven reporter genes with high efficiency. Whether differentiated cells derived from human ES and EC cells retain this activity is unknown and need to be investigated before large-scale comparative reporter-based transfection studies can be used as a tool in human embryonic stem cell biology.

Entities:  

Mesh:

Year:  2008        PMID: 18588473     DOI: 10.2217/17460751.3.4.505

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  12 in total

Review 1.  Human-induced pluripotent stem cells: in quest of clinical applications.

Authors:  Rosalinda Madonna
Journal:  Mol Biotechnol       Date:  2012-10       Impact factor: 2.695

2.  Clonality of mouse and human cardiomyogenesis in vivo.

Authors:  Toru Hosoda; Domenico D'Amario; Mauricio Castro Cabral-Da-Silva; Hanqiao Zheng; M Elena Padin-Iruegas; Barbara Ogorek; João Ferreira-Martins; Saori Yasuzawa-Amano; Katsuya Amano; Noriko Ide-Iwata; Wei Cheng; Marcello Rota; Konrad Urbanek; Jan Kajstura; Piero Anversa; Annarosa Leri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

3.  Use of UTF1 genetic control elements as iPSC reporter.

Authors:  Amir Morshedi; Monireh Soroush Noghabi; Peter Dröge
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

4.  Wnt/β-catenin signaling promotes self-renewal and inhibits the primed state transition in naïve human embryonic stem cells.

Authors:  Zhuojin Xu; Aaron M Robitaille; Jason D Berndt; Kathryn C Davidson; Karin A Fischer; Julie Mathieu; Jennifer C Potter; Hannele Ruohola-Baker; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

5.  Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines.

Authors:  Lois A Annab; Carl D Bortner; Marie I Sifre; Jennifer M Collins; Ruchir R Shah; Darlene Dixon; H Karimi Kinyamu; Trevor K Archer
Journal:  Differentiation       Date:  2012-08-18       Impact factor: 3.880

6.  Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction.

Authors:  Xian-Liang Tang; Gregg Rokosh; Santosh K Sanganalmath; Fangping Yuan; Hiroshi Sato; Jianyao Mu; Shujing Dai; Chengxin Li; Ning Chen; Yong Peng; Buddhadeb Dawn; Greg Hunt; Annarosa Leri; Jan Kajstura; Sumit Tiwari; Gregg Shirk; Piero Anversa; Roberto Bolli
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

7.  Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors.

Authors:  Pilar Muñoz; Miguel G Toscano; Pedro J Real; Karim Benabdellah; Marién Cobo; Clara Bueno; Verónica Ramos-Mejía; Pablo Menendez; Per Anderson; Francisco Martín
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

8.  Characterization of constitutive promoters for piggyBac transposon-mediated stable transgene expression in mesenchymal stem cells (MSCs).

Authors:  Sheng Wen; Hongmei Zhang; Yasha Li; Ning Wang; Wenwen Zhang; Ke Yang; Ningning Wu; Xian Chen; Fang Deng; Zhan Liao; Junhui Zhang; Qian Zhang; Zhengjian Yan; Wei Liu; Zhonglin Zhang; Jixing Ye; Youlin Deng; Guolin Zhou; Hue H Luu; Rex C Haydon; Lewis L Shi; Tong-Chuan He; Guanghui Wei
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

9.  Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system.

Authors:  Xiang Chen; Jing Cui; Zhengjian Yan; Hongmei Zhang; Xian Chen; Ning Wang; Palak Shah; Fang Deng; Chen Zhao; Nisha Geng; Melissa Li; Sahitya K Denduluri; Rex C Haydon; Hue H Luu; Russell R Reid; Tong-Chuan He
Journal:  Genes Dis       Date:  2015-03

10.  Using Zinc Finger Nuclease Technology to Generate CRX-Reporter Human Embryonic Stem Cells as a Tool to Identify and Study the Emergence of Photoreceptors Precursors During Pluripotent Stem Cell Differentiation.

Authors:  Joseph Collin; Carla B Mellough; Birthe Dorgau; Stefan Przyborski; Inmaculada Moreno-Gimeno; Majlinda Lako
Journal:  Stem Cells       Date:  2015-11-26       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.